CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01731119
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:32.144193+00:00
Published At: 2017-05-17T00:00:00+00:00
Record Updated At: 2017-06-14
Results Posted At: 2017-05-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Schizophrenia", "Schizoaffective Disorder", "Schizophreniform Disorder", "Psychosis NOS", "Autistic Disorder", "Asperger Syndrome", "Child Development Disorders, Pervasive", "Bipolar I Disorder", "Bipolar II Disorder", "Mood Disorder NOS", "Severe Major Depression With Psychotic Features", "Single Episode Major Depression Without Psychotic Symptoms", "Severe Mood Disorder With Psychotic Features"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-06-14"
protocolSection.identificationModule.nctId: "NCT01731119"
protocolSection.identificationModule.officialTitle: "An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-05-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.